Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Syndax Pharmaceuticals (SNDX) Long-Term Debt Issuances (2020)

Syndax Pharmaceuticals has reported Long-Term Debt Issuances over the past 1 years, most recently at $19.7 million for Q1 2020.

  • Quarterly results put Long-Term Debt Issuances at $19.7 million for Q1 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $19.7 million (changed N/A YoY), and the annual figure for FY2020 was $19.7 million, changed.
  • Long-Term Debt Issuances for Q1 2020 was $19.7 million at Syndax Pharmaceuticals.
  • Over the last five years, Long-Term Debt Issuances for SNDX hit a ceiling of $19.7 million in Q1 2020 and a floor of $19.7 million in Q1 2020.